Pleiotropic mechanisms of virus survival and persistence

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 100, Issue 2 SUPPL., 2005, Pages

  Miller, Craig S ^a,b,c  

^a Division of Restorative and Prosthetic Dentistry   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22244439516     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2005.03.017     Document Type: Article

References (95)

1. A.J. Levine The origins of virology D.M. Knipe P.M. Howley Fields virology 2001 Lippincott Williams & Wilkins Philadelphia 1 18
2. G.D. Likely, K.K. Sanford, and W.R. Earle Further studies on the proliferation in vitro of single isolated tissue cells J Natl Cancer Inst 13 1952 177 184
3. K.K. Sanford, G.D. Likely, W.R. Bryan, and W.R. Earle The infection of cells in tissue culture with Rous sarcoma virus J Natl Cancer Inst 12 1952 1317 1343
4. J.D. Watson, and F.H. Crick The structure of DNA Cold Spring Harb Symp Quant Biol 18 1953 123 131
5. H.L. Bachrach, J.J. Callis, W.R. Hess, and R.E. Patty A plaque assay for foot-and-mouth disease virus and kinetics of virus reproduction Virology 4 1957 224 236
6. T.W. Geisbert, and P.B. Jahrling Exotic emerging viral diseases: progress and challenges Nat Med 10 12 Suppl 2004 S110 S121
7. Y. Yang, C.T. Huang, X. Huang, and D.M. Pardoll Persistent toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance Nat Immunol 5 2004 508 515
8. L.J. Earp, S.E. Delos, H.E. Park, and J.M. White The many mechanisms of viral membrane fusion proteins Curr Top Microbiol Immunol 285 2005 25 66
9. O. Dery, C.U. Corvera, M. Steinhoff, and N.W. Bunnett Proteinase-activated receptors: novel mechanisms of signaling by serine proteases Am J Physiol 274 1998 C1429 C1452
10. F. Martinon, and J. Tschopp Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases Cell 117 2004 561 574
11. J.A. Gracie, S.E. Robertson, and I.B. McInnes Interleukin-18 J Leukoc Biol 73 2003 213 224
12. H. Hisamatsu, N. Shimbara, Y. Saito, P. Kristensen, K.B. Hendil, and T. Fujiwara Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma J Exp Med 183 1996 1807 1816
13. H. Everett, and G. McFadden Apoptosis: an innate immune response to virus infection Trends Microbiol 7 1999 160 165
14. Y. Shen, and T.E. Shenk Viruses and apoptosis Curr Opin Genet Dev 5 1995 105 111
15. E. White Life, death, and the pursuit of apoptosis Genes Dev 10 1996 1 15
16. J.G. Teodoro, and P.E. Branton Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5 J Virol 71 1997 3620 3627
17. G. Bilbao, J.L. Contreras, H.G. Zhang, M.J. Pike, K. Overturf, and G. Mikheeva Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic Bcl-2 gene J Virol 73 1999 6992 7000
18. B.W. Grinnell, and R.R. Wagner Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding Mol Cell Biol 5 1985 2502 2513
19. B.W. Richter, and C.S. Duckett The IAP proteins: caspase inhibitors and beyond Sci STKE 2000 2000 PE1
20. V. Gagliardini, P.A. Fernandez, R.K. Lee, H.C. Drexler, R.J. Rotello, and M.C. Fishman Prevention of vertebrate neuronal death by the crmA gene Science 263 1994 826 828
21. J.C. Wilkinson, A.S. Wilkinson, F.L. Scott, R.A. Csomos, G.S. Salvesen, and C.S. Duckett Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition J Biol Chem 279 2004 51082 51090
22. A. Skaletskaya, L.M. Bartle, T. Chittenden, A.L. McCormick, E.S. Mocarski, and V.S. Goldmacher A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation Proc Natl Acad Sci U S A 98 2001 7829 7834
23. Q. Sun, S. Zachariah, and P.M. Chaudhary The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation J Biol Chem 278 2003 52437 52445
24. V.S. Goldmacher vMIA, a viral inhibitor of apoptosis targeting mitochondria Biochimie 84 2002 177 185
25. V.S. Goldmacher, L.M. Bartle, A. Skaletskaya, C.A. Dionne, N.L. Kedersha, and C.A. Vater A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2 Proc Natl Acad Sci U S A 96 1999 12536 12541
26. A.H. Koyama, and A. Adachi Induction of apoptosis by herpes simplex virus type 1 J Gen Virol 78 1997 2909 2912
27. G. Zhou, V. Galvan, G. Campadelli-Fiume, and B. Roizman Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins J Virol 74 2000 11782 11791
28. L. Benetti, and B. Roizman Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis Proc Natl Acad Sci U S A 101 2004 9411 9416
29. P.D. Ogg, P.J. McDonell, B.J. Ryckman, C.M. Knudson, and R.J. Roller The HSV-1 Us3 protein kinase is sufficient to block apoptosis induced by overexpression of a variety of Bcl-2 family members Virology 319 2004 212 224
30. C.M. Sanfilippo, F.N. Chirimuuta, and J.A. Blaho Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells J Virol 78 2004 224 239
31. M. Diaz-Guerra, C. Rivas, and M. Esteban Full activation of RNaseL in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme J Interferon Cytokine Res 19 1999 113 119
32. A. Zhou, J. Paranjape, T.L. Brown, H. Nie, S. Naik, and B. Dong Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L EMBO J 16 1997 6355 6363
33. B.M. Polster, J. Pevsner, and J.M. Hardwick Viral Bcl-2 homologs and their role in virus replication and associated diseases Biochim Biophys Acta 1644 2004 211 227
34. A. Isaacs, and J. Lindenmann Virus interference. I. The interferon Proc R Soc Lond B Biol Sci 147 1957 258 267
35. G.L. Davis Treatment of acute and chronic hepatitis C Clin Liver Dis 1 1997 615 630
36. M.J. Grubman New approaches to rapidly control foot-and-mouth disease outbreaks Expert Rev Anti Infect Ther 1 2003 579 586
37. L. Malmgaard Induction and regulation of IFNs during viral infections J Interferon Cytokine Res 24 2004 439 454
38. D.M. Knipe, C.E. Samuel, and P. Palese Virus-host cell interactions D.M. Knipe P.M. Howley D.E. Griffine R.A. Lamb M.A. Martin B. Roizman Fields Virology 2001 Lippincott Williams & Wilkins Philadelphia 133 170
39. A.M. Ackrill, G.R. Foster, C.D. Laxton, D.M. Flavell, G.R. Stark, and I.M. Kerr Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene Nucleic Acids Res 19 1991 4387 4393
40. H.G. Burgert, Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windheim, and A. Elsing Subversion of host defense mechanisms by adenoviruses Curr Top Microbiol Immunol 269 2002 273 318
41. J.J. Rodriguez, and C.M. Horvath Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus V proteins inhibit interferon signaling Viral Immunol 17 2004 210 219
42. B. Precious, D.F. Young, L. Andrejeva, S. Goodbourn, and R.E. Randall In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2 J Gen Virol 86 2005 151 158
43. M. Fukushi, M. Higuchi, M. Oie, T. Tetsuka, F. Kasolo, and K. Ichiyama Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with human myeloid cell nuclear differentiation antigen induced by interferon alpha Virus Genes 27 2003 237 247
44. R. Renne, C. Barry, D. Dittmer, N. Compitello, P.O. Brown, and D. Ganem Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus J Virol 75 2001 458 468
45. A.E. Koromilas, S. Li, and G. Matlashewski Control of interferon signaling in human papillomavirus infection Cytokine Growth Factor Rev 12 2001 157 170
46. S.J. Um, J.W. Rhyu, E.J. Kim, K.C. Jeon, E.S. Hwang, and J.S. Park Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo Cancer Lett 179 2002 205 212
47. G.L. Smith, J.A. Symons, and A. Alcami Poxviruses: interfering with interferon Semin Virol 8 1998 409 418
48. A. Alcami, J.A. Symons, and G.L. Smith The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN J Virol 74 2000 11230 11239
49. S.J. Gao, C. Boshoff, S. Jayachandra, R.A. Weiss, Y. Chang, and P.S. Moore KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway Oncogene 15 1997 1979 1985
50. C.E. Samuel Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities Virology 183 1 1991 1 11
51. M.B. Mathews, and T. Shenk Adenovirus virus-associated RNA and translation control J Virol 65 1991 5657 5662
52. C.E. Samuel Antiviral actions of interferons Clin Microbiol Rev 14 2001 778 809 table of contents
53. N. Desloges, M. Rahaus, and M.H. Wolff Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon J Gen Virol 86 2005 1 6
54. R. Tomazin, A.B. Hill, P. Jugovic, I. York, P. van Endert, and H.L. Ploegh Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP EMBO J 15 1996 3256 3266
55. P.J. Lehner, J.T. Karttunen, G.W. Wilkinson, and P. Cresswell The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation Proc Natl Acad Sci U S A 94 1997 6904 6909
56. H. Farrell, M. Degli-Esposti, E. Densley, E. Cretney, M. Smyth, and N. Davis-Poynter Cytomegalovirus MHC class I homologues and natural killer cells: an overview Microbes Infect 2 2000 521 532
57. Y. Yin, B. Manoury, and R. Fahraeus Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1 Science 301 2003 1371 1374
58. N.P. Dantuma, A. Sharipo, and M.G. Masucci Avoiding proteasomal processing: the case of EBNA1 Curr Top Microbiol Immunol 269 2002 23 36
59. L. Coscoy, and D. Ganem Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis Proc Natl Acad Sci U S A 97 2000 8051 8056
60. U. Reusch, W. Muranyi, P. Lucin, H.G. Burgert, H. Hengel, and U.H. Koszinowski A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation EMBO J 18 1999 1081 1091
61. J. Trgovcich, D. Johnson, and B. Roizman Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1 J Virol 76 2002 6974 6986
62. K.L. Collins, B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397 401
63. J.V. Garcia, and A.D. Miller Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef Nature 350 1991 508 511
64. V. Piguet, Y.L. Chen, A. Mangasarian, M. Foti, J.L. Carpentier, and D. Trono Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes EMBO J 17 1998 2472 2481
65. N.T. Georgopoulos, J.L. Proffitt, and G.E. Blair Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins Oncogene 19 2000 4930 4935
66. V. Piguet Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation Curr Top Microbiol Immunol 285 2005 199 217
67. R. Sallie Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation Virol J 2 2005 10
68. J.A. Terwee, J.K. Yactor, K.S. Sondgeroth, and S. Vandewoude Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity J Virol 79 2005 2797 2806
69. A.U. Neumann, N.P. Lam, H. Dahari, D.R. Gretch, T.E. Wiley, and T.J. Layden Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy Science 282 1998 103 107
70. J.J. Feld, and T.J. Liang HCV persistence: cure is still a four letter word Hepatology 41 2005 23 25
71. M. Radkowski, J.F. Gallegos-Orozco, J. Jablonska, T.V. Colby, B. Walewska-Zielecka, and J. Kubicka Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C Hepatology 41 2005 106 114
72. C.S. Miller, P.S. Bhattacharjee, S. Higaki, R.J. Jacob, R.J. Danaher, and H.W. Thompson Herpesvirus quiescence (QIF) in neuronal cells VI: correlative analysis demonstrates usefulness of QIF-PC12 cells to examine HSV-1 latency and reactivation and deregulated LAT ORF Expression Curr Eye Res 26 2003 239 248
73. R.J. Danaher, R.J. Jacob, and C.S. Miller Establishment of a quiescent herpes simplex virus type 1 infection in neurally differentiated PC12 cells J Neurovirol 5 1999 258 267
74. R.J. Danaher, R.J. Jacob, M. Chorak, C.S. Freeman, and C.S. Miller Heat stress activates production of herpes simplex virus type 1 from quiescently infected neurally differentiated PC12 cells J Neurovirol 5 1999 374 383
75. H. Sakai, R. Shibata, J. Sakuragi, S. Sakuragi, M. Kawamura, and A. Adachi Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles J Virol 67 1993 1663 1666
76. Y. Wei, J.E. Tavis, and D. Ganem Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses J Virol 70 1996 6455 6458
77. Y. Iwatani, K. Kawano, T. Ueno, M. Tanaka, A. Ishimoto, and M. Ito Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1 Virology 286 2001 45 53
78. L. Su, H. Kaneshima, M.L. Bonyhadi, R. Lee, J. Auten, and A. Wolf Identification of HIV-1 determinants for replication in vivo Virology 227 1997 45 52
79. M.S. Longworth, and L.A. Laimins Pathogenesis of human papillomaviruses in differentiating epithelia Microbiol Mol Biol Rev 68 2004 362 372
80. D. Spector, F. Purves, and B. Roizman Role of alpha-transinducing factor (VP16) in the induction of alpha genes within the context of viral genomes J Virol 65 1991 3504 3513
81. A.E. Sears, V. Hukkanen, M.A. Labow, A.J. Levine, and B. Roizman Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice J Virol 65 1991 2929 2935
82. I. Steiner, J.G. Spivack, S.L. Deshmane, C.I. Ace, C.M. Preston, and N.W. Fraser A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia J Virol 64 1990 1630 1638
83. M. Iizuka, and M.M. Smith Functional consequences of histone modifications Curr Opin Genet Dev 13 2003 154 160
84. S.I. Grewal, and D. Moazed Heterochromatin and epigenetic control of gene expression Science 301 2003 798 802
85. J.A. Murphy, R.J. Duerst, T.J. Smith, and L.A. Morrison Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo J Virol 77 2003 9337 9345
86. P.J. Jenkins, U.K. Binne, and P.J. Farrell Histone acetylation and reactivation of Epstein-Barr virus from latency J Virol 74 2000 710 720
87. R. Lu, and V. Misra Potential role for luman, the cellular homologue of herpes simplex virus VP16 (alpha gene trans-inducing factor), in herpesvirus latency J Virol 74 2000 934 943
88. J.P. Quinn, R.A. McGregor, C.E. Fiskerstrand, C. Davey, J. Allan, and R.G. Dalziel Identification of a novel multifunctional structural domain in the herpes simplex virus type 1 genome: implications for virus latency J Gen Virol 79 1998 2529 2532
89. A.G. West, M. Gaszner, and G. Felsenfeld Insulators: many functions, many mechanisms Genes Dev 16 2002 271 288
90. D.A. Garber, P.A. Schaffer, and D.M. Knipe A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1 J Virol 71 1997 5885 5893
91. A. Cereseto, and M. Giacca Integration site selection by retroviruses AIDS Rev 6 2004 13 21
92. S.S. Wang, and A. Hildesheim Viral and host factors in human papillomavirus persistence and progression J Natl Cancer Inst Monogr 2003 35 40
93. G. Klein Perspectives in studies of human tumor viruses Front Biosci 7 2002 268 274
94. S. Collot-Teixeira, J. Bass, F. Denis, and S. Ranger-Rogez Human tumor suppressor p53 and DNA viruses Rev Med Virol 14 2004 301 319
95. Y. Nagai, T. Toma, H. Moromizato, T. Maehama, T. Asato, and K. Kariya Persistence of human papillomavirus infection as a predictor for recurrence in carcinoma of the cervix after radiotherapy Am J Obstet Gynecol 191 2004 1907 1913